| 产品名称 |
点击数 |
| VHH-mFc Isotype Control Antibody, PerCP|VHH-mFc同型对照抗体,PerCP(靶标:纳米抗体-小鼠Fc融合同型对照) |
374 |
| VHH-hFc (IgG1) Isotype Control Antibody, PerCP|VHH-hFc(IgG1)同型对照抗体,PerCP(靶标:纳米抗体-人IgG1 Fc融合同型对照) |
157 |
| Anti-Human CDH19/Cadherin-19 Recombinant Antibody , PerCP|抗人CDH19/Cadherin-19重组抗体,PerCP(靶标:人钙黏蛋白19) |
303 |
| Anti-sLea/CA19-9 Recombinant Antibody, PerCP|抗sLea/CA19-9重组抗体,PerCP(靶标:癌抗原19-9(唾液酸化Lewis A)) |
163 |
| Anti-sLea/CA19-9 Recombinant Antibody, PerCP|抗sLea/CA19-9重组抗体,PerCP(靶标:癌抗原19-9(唾液酸化Lewis A)) |
170 |
| Anti-Human ENTPD2/CD39L1 Recombinant Antibody , PerCP|抗人ENTPD2/CD39L1重组抗体,PerCP(靶标:人外核苷三磷酸二磷酸水解酶2) |
239 |
| Anti-Mouse ENTPD2/CD39L1 Recombinant Antibody , PerCP|抗小鼠ENTPD2/CD39L1重组抗体,PerCP(靶标:小鼠外核苷三磷酸二磷酸水解酶2) |
183 |
| Anti-Human P2RX4 Recombinant Antibody , PerCP|抗人P2RX4重组抗体,PerCP(靶标:人P2X嘌呤受体4) |
463 |
| Anti-Human TMEFF1 Recombinant Antibody, PerCP|抗人TMEFF1重组抗体,PerCP(靶标:人跨膜蛋白含EGF样和卵泡抑素样结构域1) |
509 |
| Anti-Human HS6ST2 Recombinant Antibody , PerCP|抗人HS6ST2重组抗体,PerCP(靶标:人硫酸乙酰肝素6-O-磺基转移酶2) |
232 |
| Anti-Human HS6ST2 Recombinant Antibody , PerCP|抗人HS6ST2重组抗体,PerCP(靶标:人硫酸乙酰肝素6-O-磺基转移酶2) |
303 |
| Anti-Mouse TER-119/Erythroid Cells Recombinant Antibody, PerCP|抗小鼠TER-119/红细胞重组抗体,PerCP(靶标:小鼠红细胞抗原TER-119) |
318 |
| Anti-Human GPC2/Glypican-2 Recombinant Antibody , PerCP|抗人GPC2/Glypican-2重组抗体,PerCP(靶标:人磷脂酰肌醇蛋白聚糖2) |
182 |
| Anti-Human GPC2/Glypican-2 Recombinant Antibody, PerCP|抗人GPC2/Glypican-2重组抗体,PerCP(靶标:人磷脂酰肌醇蛋白聚糖2) |
217 |
| Anti-Human LAMP5 Recombinant Antibody, PerCP|抗人LAMP5重组抗体,PerCP(靶标:人溶酶体相关膜蛋白5) |
421 |
| Anti-Human CADM3/NECL-1/TSLL1 Recombinant Antibody , PerCP|抗人CADM3/NECL-1/TSLL1重组抗体,PerCP(靶标:人细胞黏附分子3) |
190 |
| Anti-Human HLA-A, B, C Recombinant Antibody, PerCP|抗人HLA-A、B、C重组抗体,PerCP(靶标:人MHC I类HLA-A/B/C) |
329 |
| Anti-Human HLA-B*27 Recombinant Antibody, PerCP|抗人HLA-B*27重组抗体,PerCP(靶标:人HLA-B*27) |
193 |
| Anti-Human HLA-DRA Recombinant Antibody, PerCP|抗人HLA-DRA重组抗体,PerCP(靶标:人MHC II类HLA-DRA) |
241 |
| Anti-Human HLA-DRB1 Recombinant Antibody, PerCP|抗人HLA-DRB1重组抗体,PerCP(靶标:人MHC II类HLA-DRB1) |
124 |